Anterior ischemic optic neuropathy

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Friday, June 11, 2021

Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering").

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering").
  • Each Unit is comprised of one common share (each, a "Common Share") of the Company and one-half of one Common Share purchase warrant (each whole warrant, a "Warrant").
  • Each Warrant entitles the holder thereof to acquire one Common Share for a period of twenty-four months from the closing of the Offering (the "Expiry Date") at a price of $0.15 per Common Share.
  • In addition, Aion Therapeutic is creating a strong international intellectual property portfolio related to its discoveries.

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

Retrieved on: 
Thursday, March 11, 2021

TORONTO, March 11, 2021 /PRNewswire/ - Aion Therapeutic Inc. (CSE: AION)("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms.

Key Points: 
  • TORONTO, March 11, 2021 /PRNewswire/ - Aion Therapeutic Inc. (CSE: AION)("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms.
  • These new additions increase our intellectual property portfolio to a current total of 9 patent applications with more expected in the very near future.
  • Dr. Fritsche continued, "We intend to announce the details of these very exciting discoveries now that the patents have been filed."
  • In addition, Aion Therapeutic is creating a strong international intellectual property portfolio related to its discoveries.

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

Retrieved on: 
Thursday, March 11, 2021

TORONTO, March 11, 2021 /PRNewswire/ -- Aion Therapeutic Inc. (CSE: AION)("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms.

Key Points: 
  • TORONTO, March 11, 2021 /PRNewswire/ -- Aion Therapeutic Inc. (CSE: AION)("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms.
  • These new additions increase our intellectual property portfolio to a current total of 9 patent applications with more expected in the very near future.
  • Dr. Fritsche continued, "We intend to announce the details of these very exciting discoveries now that the patents have been filed."
  • Investor Relations & Financial Media: Integrity Media Inc., [email protected] , Toll Free: (888) 216-3595, www.IntegrityMedia.com ; Aion Therapeutic Inc., Graham Simmonds, Executive Vice Chair & CEO, (416) 843-2881

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director

Retrieved on: 
Tuesday, February 23, 2021

Toronto, Ontario--(Newsfile Corp. - February 23, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today the opening of the Aion International Center for Psychedelic Psychiatry in Jamaica.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - February 23, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today the opening of the Aion International Center for Psychedelic Psychiatry in Jamaica.
  • "[2]
    The Medical Director of the Aion International Center for Psychedelic Psychiatry is Winston De La Haye, M.D., M.P.H, D.M., I.C.A.P.
  • Dr. Stephen Barnhill, Executive Chairman of Aion Therapeutic, stated, "We're very excited to be opening the first International Center for Psychedelic Psychiatry in Jamaica.
  • The offices of Aion International Center for Psychedelic Psychiatry will soon be opened for seeing both Jamaican and international patients.

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Monday, February 22, 2021

Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 6,666,333 units ("Units") at a price of $0.075 per Unit for gross proceeds of approximately $499,975 (the "Offering").

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 6,666,333 units ("Units") at a price of $0.075 per Unit for gross proceeds of approximately $499,975 (the "Offering").
  • Each Unit is comprised of one common share ("Common Share") of the Company and one-half of one Common Share purchase warrant (each whole warrant, a "Warrant").
  • Aion Therapeutic Inc. (formerly, Osoyoos Cannabis Inc.) has a joint-venture agreement with a private, vertically-integrated licensed producer under the Cannabis Act (Canada) to offer contract tolling extraction services to third-party businesses.
  • Ltd. d/b/a "PCAI Pharma" ( www.pcai.ca ) and its wholly-owned subsidiary AI Pharmaceuticals Jamaica Limited, a private corporation incorporated and operating under the laws of Jamaica.

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Wednesday, December 23, 2020

Toronto, Ontario--(Newsfile Corp. - December 23, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 15,384,615 units ("Units") at a price of $0.065 per Unit for gross proceeds of $1,000,000 (the "Offering").

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - December 23, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 15,384,615 units ("Units") at a price of $0.065 per Unit for gross proceeds of $1,000,000 (the "Offering").
  • Each Unit is comprised of one common share ("Common Share") of the Company and one-half of one Common Share purchase warrant (each whole warrant, a "Warrant").
  • Aion Therapeutic Inc. (formerly, Osoyoos Cannabis Inc.) has a joint-venture agreement with a private, vertically-integrated licensed producer under the Cannabis Act (Canada) to offer contract tolling extraction services to third-party businesses.
  • Ltd. d/b/a "PCAI Pharma" ( www.pcai.ca ) and its wholly-owned subsidiary AI Pharmaceuticals Jamaica Limited, a private corporation incorporated and operating under the laws of Jamaica.

Psychic Predictions - What will happen in the next 20 years according to Kasamba's gurus?

Retrieved on: 
Wednesday, September 23, 2020

Humanity has made unprecedented wavelengths in technology, medicine, and infrastructure and we have never been more advanced than now.

Key Points: 
  • Humanity has made unprecedented wavelengths in technology, medicine, and infrastructure and we have never been more advanced than now.
  • Psychic Debbie added that there would be changes in currency in the next 20 years too.
  • Psychic Totem Aion noted what will happen to relationships in the next 20 years explaining This will be a testing period for all kinds of relationships.
  • In 20 years of Kasamba, countless relationships and bonds have been made stronger through the guidance and insights of our advisors.